The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors

Objective: This study aimed to investigate the prognostic value of the gastric immune prognostic index (GIPI) in gastric cancer patients treated with programmed death 1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors. Methods: This study was conducted to elucidate the role of GIPI using the data f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Zhao, Ruihu, Sun, Hao, Huang, Rong, Pan, Hongming, Zuo, Yanjiao, Zhang, Lele, Xue, Yingwei, Li, Xingrui, Song, Hongjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251404/
https://www.ncbi.nlm.nih.gov/pubmed/35795575
http://dx.doi.org/10.3389/fphar.2022.833584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251404/
https://www.ncbi.nlm.nih.gov/pubmed/35795575
http://dx.doi.org/10.3389/fphar.2022.833584

Ejemplares similares